Basal-bolus insulin therapy for the treatment of non-critically ill patients with type 2 diabetes in Vietnam: effectiveness and factors associated with inpatient glycemic control

被引：0
|
作者：
Mai Ngoc Thi Tran
Khiem Tran Dang
Luong Dai Ly
Nam Quang Tran
机构：
[1] University of Medicine and Pharmacy at Ho Chi Minh City,Department of Endocrinology
[2] Endocrinology Clinic,Department of Surgery
[3] My Duc Hospital,Department of Endocrinology
[4] University of Medicine and Pharmacy at Ho Chi Minh City,Department of Endocrinology
[5] Grant and Innovation Center,undefined
[6] University of Medicine and Pharmacy at Ho Chi Minh City,undefined
[7] Vietnam National University,undefined
[8] University Medical Center at Ho Chi Minh City,undefined
来源：
International Journal of Diabetes in Developing Countries | 2023年 / 43卷
关键词：
Type 2 diabetes mellitus; Inpatient glycemic control; Basal–bolus insulin therapy; Snack consumption; Glucocorticoid use;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：199 / 207
页数：8
相关论文
共 50 条
  • [21] EVALUATION OF GLYCEMIC CONTROL USING AN ALGORITHM FOR BASAL BOLUS INSULIN THERAPY IN HOSPITALISED PATIENTS WITH DIABETES MELLITUS TYPE 2
    Mader, J. K.
    Neubauer, K. M.
    Schaupp, L.
    Aberer, F.
    Augustin, T.
    Spat, S.
    Hoell, B.
    Beck, P.
    Plank, J.
    Pieber, T. R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A8 - A8
  • [22] Introduction of insulin glargine to basal-bolus therapy improves metabolic control in patients with type 2 diabetes in everyday clinical practice
    Ruhnau, KJ
    Schneider, K
    Schweitzer, MA
    DIABETES, 2005, 54 : A518 - A518
  • [23] Glycaemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with Type 2 diabetes
    Dailey, G
    Rosenstock, J
    Moses, R
    Ways, K
    DIABETOLOGIA, 2004, 47 : A265 - A266
  • [24] Introduction of insulin glargine to basal-bolus therapy improves metabolic control in patients with type 2 diabetes in everyday clinical practice
    Ruhnau, KJ
    Schneider, K
    Schweitzer, MA
    DIABETOLOGIA, 2005, 48 : A303 - A303
  • [25] Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study
    Pfohl, Martin
    Siegmund, Thorsten
    Pscherer, Stefan
    Pegelow, Katrin
    Seufert, Jochen
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 569 - 578
  • [26] Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
    Bellido, Virginia
    Suarez, Lorena
    Galiana Rodriguez, Maria
    Sanchez, Cecilia
    Dieguez, Marta
    Riestra, Maria
    Casal, Florentino
    Delgado, Elias
    Menendez, Edelmiro
    Umpierrez, Guillermo E.
    DIABETES CARE, 2015, 38 (12) : 2211 - 2216
  • [27] GlucoTab-Based Basal-Bolus Insulin Therapy for Inpatient Glycemic Control Using an Ultra-Long-Acting Insulin Analog
    Mader, Julia K.
    Donsa, Klaus
    Aberer, Felix
    Smajic, Edin
    Lanz, Christian
    Lichtenegger, Katharina M.
    Spat, Stephan
    Hoell, Bernhard
    Beck, Peter
    Pieber, Thomas R.
    Plank, Johannes
    DIABETES, 2017, 66 : A277 - A277
  • [28] HOW HYPOGLYCEMIA IMPACTS QUALITY OF LIFE AND TREATMENT SATISFACTION IN TYPE 2 DIABETES MELLITUS PATIENTS ON BASAL-BOLUS INSULIN THERAPY?
    Ionova, T. I.
    Odin, V., I
    Nikitina, T. P.
    Kurbatova, K. A.
    Shablovskaya, N. E.
    VALUE IN HEALTH, 2013, 16 (07) : A446 - A446
  • [29] CONTINUOUS GLUCOSE MONITORING ASSESSING THE CLINICAL IMPACT OF AN ALGORITHM DRIVEN BASAL-BOLUS INSULIN REGIMEN IN NON-CRITICALLY ILL INPATIENTS WITH T2DM
    Donsa, K.
    Neubauer, K. M.
    Mader, J. K.
    Hoell, B.
    Spat, S.
    Beck, P.
    Aberer, F.
    Plank, J.
    Pieber, T. R.
    Schaupp, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A24 - A25
  • [30] The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy
    Klimontov, V. V.
    Myakina, N. E.
    DIABETES MELLITUS, 2015, 18 (04): : 66 - 71
12345